APA (7th ed.) Citation

Gowen, B. B., Smee, D. F., Wong, M., Hall, J. O., Jung, K., Bailey, K. W., . . . Morrey, J. D. Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Gowen, Brian B., Donald F. Smee, Min-Hui Wong, Jeffery O. Hall, Kie-Hoon Jung, Kevin W. Bailey, John R. Stevens, Yousuke Furuta, and John D. Morrey. Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Gowen, Brian B., et al. Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin. Public Library of Science (PLoS).